2) We then showed that this signature is down-regulated after short-term letrozole in postmenopausal patients with ER+ breast cancer Samples from SOLTI-VENTANA trial (https://t.co/suo2U7mkX8) @BCRJournal https://t.co/2Pmd6rFu2q @EBioMedicine https://t.c
12,931 followers
2,357 followers
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial https://t.co/7z6wrzw99R #ScientiaVH
1,183 followers
New research: Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative #breastcancer: https://t.co/57nA5Glk7b @hospitalclinic @_SOLTI #MondayMorning https://t.co/elbyhG9lnj
27 followers